Acquired Company
Pacira BioSciences completed its acquisition of Flexion Therapeutics on November 19, 2021.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund’s Fixed Income Instruments may include debt or debt-related securities, income producing securities, and other instruments or evidences of indebtedness, including bonds, bills, notes, loans, money market instruments, mortgage and asset backed securities, and preferred stocks, and derivative instruments related thereto; and other investment companies that invest primarily in the foregoing instruments. Show more
Start AI Chat
Market Cap
0.00
52 Wk Range
$24.92 - $26.09
Previous Close
$25.68
Open
$25.68
Volume
1,905
Day Range
$25.65 - $25.70
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
